Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.10.981710905218.7537
Domestic EquitiesCipla Ltd.5.6861642519.7103
Domestic EquitiesMax Healthcare Institute Ltd.5.4087883809.2366
Domestic EquitiesDivi's Laboratories Ltd.5.0811135748.6772
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.0535122548.6299
Domestic EquitiesDr. Reddy's Laboratories Ltd.4.5891616417.8370
Domestic EquitiesLupin Ltd.3.5262285466.0218
Domestic EquitiesTorrent Pharmaceuticals Ltd.3.0345134605.1821
Domestic EquitiesFortis Healthcare Ltd.2.8865557614.9293
Domestic EquitiesLaurus Labs Ltd.2.5869398714.4177
Domestic EquitiesGlenmark Pharmaceuticals Ltd.2.1019176373.5895
Domestic EquitiesAurobindo Pharma Ltd.2.0573296983.5133
Domestic EquitiesMankind Pharma Ltd.1.8098140713.0907
Domestic EquitiesAlkem Laboratories Ltd.1.752254342.9922
Domestic EquitiesBiocon Ltd.1.4017607682.3937
Domestic EquitiesIPCA Laboratories Ltd.1.3172158532.2494
Domestic EquitiesZydus Lifesciences Ltd.1.2244228682.0909
Domestic EquitiesNarayana Hrudayalaya ltd.0.900581281.5378
Domestic EquitiesGland Pharma Ltd.0.849684251.4508
Domestic EquitiesAjanta Pharma Ltd.0.805749691.3759
Domestic EquitiesSyngene International Ltd.0.7854206041.3413
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Ltd.0.697048121.1903
Domestic EquitiesPiramal Pharma Ltd.0.6854679691.1705
Domestic EquitiesGlobal Health Ltd.0.636691631.0871
Domestic EquitiesAster DM Healthcare Ltd.0.4679129540.7991
Total 66.3269 113.2681
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd.0.1640 0.2800
Cash & Cash Equivalents and Net AssetsAccrued Interest0.0000 0.0000
Cash & Cash Equivalents and Net AssetsNet Receivables/(Payables)-0.0808 -0.1380
Total 0.0832 0.1420
Overseas EquitiesELI LILLY & CO6.9715123211.9054
Overseas EquitiesJOHNSON & JOHNSON4.016636866.8592
Overseas EquitiesABBVIE INC3.253227045.5556
Overseas EquitiesMERCK & CO.INC2.118938233.6185
Overseas EquitiesNOVARTIS AG2.112529103.6076
Overseas EquitiesTHERMO FISHER SCIENTIFIC INC1.76665793.0168
Overseas EquitiesABBOTT LABORATORIES1.757526643.0013
Overseas EquitiesINTUITIVE SURGICAL INC1.64025502.8010
Overseas EquitiesAMGEN INC1.42188252.4281
Overseas EquitiesNovo Nordisk A/S1.320549292.2551
Overseas EquitiesGILEAD SCIENCES INC1.228019002.0970
Overseas EquitiesDANAHER CORP1.18979872.0317
Overseas EquitiesMEDTRONIC PLC0.993419641.6964
Overseas EquitiesSTRYKER CORP0.97715281.6687
Overseas EquitiesVERTEX PHARMACEUTICALS INC0.93813931.6021
Overseas EquitiesRegeneron Pharmaceuticals Inc0.65031601.1105
Overseas EquitiesBECTON DICKINSON AND CO0.44964400.7678
Overseas EquitiesAGILENT TECHNOLOGIES INC0.31164350.5322
Overseas EquitiesIQVIA HOLDINGS INC0.30982610.5290
Overseas EquitiesILLUMINA INC0.16302360.2783
Total 33.5899 57.3623
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.